ARCHIVES

European Compound enhances IL-2 In BRMP Mouse Study; BRMP Mouse Study; Rosemberg Describes System Improvements, Updates Results

This article is from The Cancer Letter archive.

Vol. 13 No. 23 | June 5, 1987

Download PDF Visit The Full Archive

Related Articles

In Brief: RFPs For Recompeting Frederick Contract Still Being Drafted; Panel Meets April 13

April 10, 1981

RAS Mutations Can Predict Resistance To Vectibix, FOLFOX Combination Treatment

September 27, 2013

Bill Introduced To Curb NIH Use Of Title 42 Salaries

August 10, 2012

Celecoxib Effective To Prevent Colon Adenomas, Study Finds

April 25, 2008

In Brief: Orvile Kelley, Make Today Count Founder, Dies; Elli Kohen Honored By Pap Institute

July 4, 1980

PRI Purchased By DynCorp; NCI Is Assured No Changes Will Be Made At Frederick

April 13, 1990